The Japan Association of Corporate Executives (Keizai Doyukai) will become more active in making policy recommendations to the government, said Yasuchika Hasegawa, who chairs the major business lobby.
Keizai Doyukai will work closely with government panels to have its proposals reflected in official policy, Hasegawa said in an interview before starting his second two-year term Thursday.
He also said a considerable number of senior officials from Keizai Doyukai will join the panels.
The effort has already resulted in a plan to set up a medical research institution similar to the National Institutes of Health in the United States. The plan was announced by Prime Minister Shinzo Abe last week after Hasegawa proposed it to the government’s Industrial Competitiveness Council.
Hasegawa, president of Takeda Pharmaceutical Co., hinted he may step down from the helm of the drugmaker, noting that he is fully aware it is undesirable for him to lead both the company and the business lobby at the same time.